PHG
NYSEHealthcareLoading…
Koninklijke Philips N.V. NY Registry Shares
Sector: Healthcare•United States•Market Cap: $26.3B
Related News
Latest stories connected to PHG
- RS 74Here's Why Royal Philips (PHG) is a Strong Value StockZacks Investment Research•6d ago•Original source
- RS 74Philips launches IntraSight Plus to simplify coronary interventions and advance precision careGlobeNewsWire•6d ago•Original source
- RS 74Philips Sonicare declares World Oral Health Night, spotlighting what manual brushing leaves behindPRNewsWire•Mar 17, 2026•Original source
- RS 74Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuiteGlobeNewsWire•Mar 11, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 17.83B | 18.02B | 18.17B | 17.83B | 17.16B | 17.31B | 17.15B | 18.12B | 17.78B | 24.52B |
| Cost of Revenue | 9.78B | 10.25B | 10.72B | 10.63B | 9.99B | 9.40B | 9.20B | 9.57B | 9.60B | 13.90B |
| Gross Profit | 8.06B | 7.77B | 7.45B | 7.19B | 7.17B | 7.91B | 7.95B | 8.55B | 8.18B | 10.61B |
| Research and Development Expenses | 1.70B | 1.75B | 1.89B | 2.09B | 1.81B | 1.91B | 1.79B | 1.76B | 1.76B | 2.02B |
| General and Administrative Expenses | 628.00M | 582.00M | 608.00M | 671.00M | 599.00M | 630.00M | 586.00M | 631.00M | 577.00M | 845.00M |
| Selling and Marketing Expenses | 4.34B | 4.49B | 4.52B | 4.62B | 4.26B | 3.92B | 3.97B | 4.50B | 4.40B | 5.89B |
| Selling General and Administrative Expenses | 4.97B | 5.07B | 5.13B | 5.29B | 4.86B | 4.55B | 4.56B | 5.13B | 4.97B | 6.73B |
| Other Expenses | -36.00M | 429.00M | 541.00M | 1.34B | -48.00M | 183.00M | 232.00M | 9.00M | 21.00M | 0 |
| Operating Expenses | 6.63B | 7.24B | 7.56B | 8.72B | 6.62B | 6.65B | 6.58B | 6.83B | 6.65B | 8.73B |
| Cost and Expenses | 16.41B | 17.49B | 18.28B | 19.36B | 16.60B | 16.05B | 15.78B | 16.40B | 16.25B | 22.63B |
| Net Interest Income | -223.80M | -257.00M | -260.00M | -219.00M | -146.00M | -178.98M | -179.08M | -219.00M | -81.00M | -421.00M |
| Interest Income | 108.54M | 79.00M | 46.00M | 25.00M | 18.00M | 14.82M | 30.22M | 51.00M | 126.00M | 76.00M |
| Interest Expense | 332.34M | 337.00M | 306.00M | 244.00M | 164.00M | 193.80M | 209.30M | 264.00M | 263.00M | 569.00M |
| Depreciation and Amortization | 1.13B | 1.26B | 1.39B | 1.26B | 1.24B | 1.46B | 1.09B | 1.09B | 1.02B | 1.27B |
| EBITDA | 2.64B | 1.85B | 1.04B | 115.00M | 2.00B | 2.75B | 2.62B | 2.79B | 2.65B | 2.35B |
| EBIT | 1.51B | 460.00M | -220.00M | -1.49B | 673.00M | 1.69B | 1.72B | 1.71B | 1.62B | 1.38B |
| Non Operating Income Excluding Interest | -90.34M | 69.00M | 105.00M | -42.00M | -120.00M | -421.00M | -354.00M | 13.00M | -104.00M | 87.00M |
| Operating Income | 1.42B | 529.00M | -115.00M | -1.53B | 553.00M | 1.26B | 1.37B | 1.72B | 1.52B | 1.88B |
| Total Other Income Expenses Net | -242.00M | -406.00M | -412.00M | -202.00M | -44.00M | -53.00M | -119.00M | -216.00M | -140.00M | -75.00M |
| Income Before Tax | 1.18B | 123.00M | -527.00M | -1.73B | 509.00M | 1.21B | 1.25B | 1.50B | 1.38B | 1.39B |
| Income Tax Expense | 282.00M | 963.00M | -73.00M | -113.00M | -103.00M | 212.00M | 258.00M | 193.00M | 349.00M | 327.00M |
| Net Income From Continuing Operations | 900.00M | -840.00M | -454.00M | -1.62B | 612.00M | 999.00M | 989.00M | 1.31B | 1.03B | 831.00M |
| Net Income From Discontinued Operations | -4.00M | 142.00M | -10.00M | 13.00M | 2.71B | 196.00M | 183.00M | 0 | 843.00M | 660.00M |
| Other Adjustments To Net Income | 0 | -1.00M | 0 | 0 | 0 | 0 | 0 | -213.00M | 0 | 0 |
| Net Income | 895.00M | -912.95M | -492.99M | -1.70B | 718.64M | 1.19B | 1.33B | 1.31B | 1.03B | 1.07B |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 0.95 | -0.75 | -0.49 | -1.68 | 0.67 | 1.25 | 1.21 | 1.11 | 1.67 | 1.48 |
| EPS Diluted | 0.93 | -0.75 | -0.49 | -1.68 | 0.64 | 1.23 | 1.2 | 1.09 | 1.64 | 1.46 |
| Weighted Average SHS Out | 962.37M | 933.37M | 948.79M | 952.46M | 907.46M | 948.26M | 962.20M | 983.77M | 989.96M | 978.47M |
| Weighted Average SHS Out Dil | 962.50M | 933.37M | 948.79M | 952.46M | 950.28M | 957.56M | 972.79M | 997.48M | 1.01B | 989.95M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.45 | 0.43 | 0.41 | 0.4 | 0.42 | 0.46 | 0.46 | 0.47 | 0.46 | 0.43 |
| R&D to Revenue | 0.1 | 0.1 | 0.1 | 0.12 | 0.11 | 0.11 | 0.1 | 0.1 | 0.1 | 0.08 |
| SG&A to Revenue | 0.04 | 0.03 | 0.03 | 0.04 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 |
| Interest Burden | 0.78 | 0.27 | 2.4 | 1.16 | 0.76 | 0.72 | 0.73 | 0.88 | 0.85 | 1.01 |
| EBIT Margin | 0.08 | 0.03 | -0.01 | -0.08 | 0.04 | 0.1 | 0.1 | 0.09 | 0.09 | 0.06 |
| EBITDA Margin | 0.15 | 0.1 | 0.06 | 0.01 | 0.12 | 0.16 | 0.15 | 0.15 | 0.15 | 0.1 |
| EBT per EBIT | 0.83 | 0.23 | 4.58 | 1.13 | 0.92 | 0.96 | 0.91 | 0.87 | 0.91 | 0.74 |
| Effective Tax Rate | 0.24 | 7.83 | 0.14 | 0.07 | -0.2 | 0.18 | 0.21 | 0.13 | 0.25 | 0.24 |
| Tax Burden | 0.76 | -5.71 | 0.88 | 0.93 | 6.52 | 0.98 | 0.94 | 0.73 | 1.2 | 1.04 |
| Cont. Operations Profit Margin | 0.05 | -0.05 | -0.02 | -0.09 | 0.04 | 0.06 | 0.06 | 0.07 | 0.06 | 0.03 |
| Bottom Line Profit Margin | 0.05 | -0.04 | -0.03 | -0.09 | 0.04 | 0.06 | 0.06 | 0.06 | 0.09 | 0.06 |
| Operating Cycle | 179.4 | 188.28 | 204.25 | 234.26 | 217.31 | 203.84 | 216.86 | 186.24 | 175.77 | 172.85 |
| Fwd PEG Ratio | -0.11 | -0.61 | 0.59 | 0.02 | -0.18 | 9.91 | 3.61 | -0.75 | 1.33 | 0.14 |
| Earnings Yield | 0.04 | -0.03 | -0.02 | -0.12 | 0.12 | 0.03 | 0.03 | 0.04 | 0.06 | 0.06 |
| Income Quality | 1.3 | -1.86 | -4.68 | 0.11 | 2.68 | 2.22 | 1.71 | 1.36 | 1.82 | 1.77 |